Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3,900.00p
   
  • Change Today:
      30.00p
  • 52 Week High: 4,270.00
  • 52 Week Low: 2,915.00
  • Currency: UK Pounds
  • Shares Issued: 5.21m
  • Volume: 2,828
  • Market Cap: £203.16m

Bioventix Overview

Bioventix was founded in 2003 as a biotechnology company specialising in the creation and supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics. However, the antibody technology laboratory and some of the staff have been based at the same location in Farnham, Surrey, UK since the early 1990s.

1 Day Chart (02-02-2023)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 3.2% 0.0%
Div Cover 1.2 1.1
Op Mrgn 79.1% 79.7%
ROCE 78.2%  
Latest F'cast
P/E 26.5 25.9
PEG 1.9 7.5
Pr/Revenue 17.3 16.1
Pr/Book 17.2  
Latest F'cast
Revenue 7.2% 9.2%
PBT 14.3% 9.9%
EPS 14.0% 3.4%
DPS 20.0% 9.5%

Bioventix Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-18 7.98 6.87 110.21p 26.7 1.9 +14% 61.00p 2.1%
30-Jun-19 9.29 6.97 114.04p 32.8 8.2 +4% 73.00p 2.0%
30-Jun-20 10.31 8.23 139.41p 29.8 1.4 +22% 88.00p 2.1%
30-Jun-21 10.93 8.12 129.22p 30.7 n/a -7% 105.00p 2.6%
30-Jun-22 11.72 9.28 147.32p 23.4 1.7 +14% 126.00p 3.7%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Bioventix Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-23 12.80 10.20 152.40p 25.6 7.4 +3% 138.00p 0.0%
30-Jun-24 13.90 11.10 165.60p 23.6 2.7 +9% 152.00p 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Bioventix Company Announcements

Director/PDMR Shareholding 31-Jan-2023 17:03 RNS
Holding(s) in Company 25-Jan-2023 15:23 RNS
Bioventix Plc - Holding(s) in Company 29-Dec-2022 15:03 PR Newswire

Bioventix ShareCast News

BioVentix revenue, profits improve in full-year ... 24-Oct-2022 ShareCast
Bioventix hikes interim dividend after revenue f... 28-Mar-2022 ShareCast
Bioventix revenue rises in tougher first half 29-Mar-2021 ShareCast

Latest Bioventix Director Deals

Traded Action Notifier PriceAmountValue
31-Jan-23 Sell Ian James Nicholson 3,750.00p 1,600 £60,000.00
31-Jan-23 Sell Nicholas (Nick) John McCooke 3,750.00p 2,752 £103,200.00
31-Jan-23 Exercise of option Nicholas (Nick) John McCooke 1,350.00p 2,752 £37,152.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Bioventix Market Data

Currency UK Pounds
Share Price 3,900.00p
Change Today 30.00p
% Change 0.78 %
52 Week High 4,270.00
52 Week Low 2,915.00
Volume 2,828
Shares Issued 5.21m
Market Cap £203.16m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
98.26% below the market average98.26% below the market average98.26% below the market average98.26% below the market average98.26% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
56.95% above the market average56.95% above the market average56.95% above the market average56.95% above the market average56.95% above the market average
70.97% above the sector average70.97% above the sector average70.97% above the sector average70.97% above the sector average70.97% above the sector average
Income
20.33% above the market average20.33% above the market average20.33% above the market average20.33% above the market average20.33% above the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Growth
44.85% below the market average44.85% below the market average44.85% below the market average44.85% below the market average44.85% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average

Bioventix Dividends

  Latest Previous
  Special 2nd Interim
Ex-Div 03-Nov-22 03-Nov-22
Paid 18-Nov-22 18-Nov-22
Amount 26.00p 74.00p

Trades for 02-Feb-2023

Time Volume / Share Price
16:30 675 @ 3,900.00p
16:08 97 @ 3,875.00p
16:06 125 @ 3,875.00p
15:32 500 @ 3,900.00p
15:30 125 @ 3,888.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page